Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Sleep Apnoea Syndrome and Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- N/A
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations
- Status
- UNKNOWN
- Phase
- N/A
LITT and Pembrolizumab in Recurrent Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE1
Neo-TACE-HAIC for PVTT-HCC
- Status
- UNKNOWN
- Phase
- NA
The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol
- Status
- WITHDRAWN
- Phase
- PHASE2
Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT
- Status
- UNKNOWN
- Phase
- PHASE2
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Changing Trends in HCC Procedures
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy
- Status
- COMPLETED
- Phase
- N/A